The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.
Georgina Long
Advertisement
Articles by Georgina Long
Advertisement
Latest Updated Articles
Clinical Trial to Evaluate Opdivo, Opdualag in GlioblastomaPublished: March 27th 2025 | Updated:
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer
2
All FDA Oncology Approvals From September 2025
3
September Blood Cancer Updates: What Patients Should Know
4
Pelvic Physical Therapy After Cancer Restores Intimacy, Wellness
5
